載入...
Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
Quadrivalent human papillomavirus (4vHPV) vaccine was licensed for use in the United States in 2006 and through 2015 was the predominate HPV vaccine used. With the exception of syncope, a known preventable adverse event after any injected vaccination, both pre-licensure and post-licensure 4vHPV safe...
Na minha lista:
| 發表在: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4964727/ https://ncbi.nlm.nih.gov/pubmed/27029786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1168952 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|